<div class="c-article-header">
    <header>
        <h1 class="c-article-title" data-test="article-title" data-article-title="">CSF tau
            microtubule-binding region identifies pathological changes in primary tauopathies</h1>
    </header>
</div>

<div class="c-article-body">
    <section aria-labelledby="Abs1" data-title="Abstract" lang="en">
        <div class="c-article-section" id="Abs1-section">
            <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">
                Abstract</h2>
            <div class="c-article-section__content" id="Abs1-content">
                <p>Despite recent advances in fluid biomarker research in Alzheimer’s disease (AD),
                    there are no fluid biomarkers or imaging tracers with utility for diagnosis and/or
                    theragnosis available for other tauopathies. Using immunoprecipitation and mass
                    spectrometry, we show that 4 repeat (4R) isoform-specific tau species from
                    microtubule-binding region (MTBR-tau<sub>275</sub> and MTBR-tau<sub>282</sub>)
                    increase in the brains of corticobasal degeneration (CBD), progressive supranuclear
                    palsy (PSP), frontotemporal lobar degeneration (FTLD)-<i>MAPT</i> and AD but
                    decrease inversely in the cerebrospinal fluid (CSF) of CBD, FTLD-<i>MAPT</i> and AD
                    compared to control and other FTLD-tau (for example, Pick’s disease). CSF MTBR-tau
                    measures are reproducible in repeated lumbar punctures and can be used to
                    distinguish CBD from control (receiver operating characteristic area under the curve
                    (AUC) = 0.889) and other FTLD-tau, such as PSP (AUC = 0.886). CSF
                    MTBR-tau<sub>275</sub> and MTBR-tau<sub>282</sub> may represent the first
                    affirmative biomarkers to aid in the diagnosis of primary tauopathies and facilitate
                    clinical trial designs.</p>
            </div>
        </div>
    </section>

    <div class="main-content">

        <section data-title="Main">
            <div class="c-article-section" id="Sec1-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">
                    Main</h2>
                <div class="c-article-section__content" id="Sec1-content">
                    <p>Tauopathies are a heterogeneous group of neurodegenerative diseases that all</p>
                </div>
            </div>
        </section>
        <section data-title="Results">
            <div class="c-article-section" id="Sec2-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">
                    Results</h2>
                <div class="c-article-section__content" id="Sec2-content">
                    <h3 class="c-article__sub-heading" id="Sec3">4R-specific brain MTBR-tau increases in
                        primary tauopathies</h3>
                    <p>First, frozen brain tissues from 59 individuals with autopsy-confirmed AD,</p>
                </div>
            </div>
        </section>
        <section data-title="Discussion">
            <div class="c-article-section" id="Sec8-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec8">
                    Discussion</h2>
                <div class="c-article-section__content" id="Sec8-content">
                    <p>Despite the long quest for antemortem biomarkers of FTLD-tau pathology, to date</p>
                </div>
            </div>
        </section>
        <section data-title="Methods">
            <div class="c-article-section" id="Sec9-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec9">
                    Methods</h2>
                <div class="c-article-section__content" id="Sec9-content">
                    <h3 class="c-article__sub-heading" id="Sec10">Human studies</h3>
                    <p>The retrospective study of pathologically confirmed cohort included participants</p>
                </div>
            </div>
        </section>

    </div>


    <div class="u-mt-32">
        <section data-title="Data availability">
            <div class="c-article-section" id="data-availability-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item"
                    id="data-availability">Data availability</h2>
                <div class="c-article-section__content" id="data-availability-content">

                    <p>The datasets generated and/or analyzed during the current study are available
                        from the corresponding author (C.S.). The data that support the findings of this
                        study are not openly available due to the human data, which is stored in a
                        controlled access repository. We will share datasets within the restrictions of
                        institutional review board ethics approvals, upon reasonable request.</p>
                </div>
            </div>
        </section>
        <section data-title="Acknowledgements">
            <div class="c-article-section" id="Ack1-section">
                <h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">
                    Acknowledgements</h2>
                <div class="c-article-section__content" id="Ack1-content">
                    <p>This work was supported by the Rainwater Charitable Foundation (R.J.B., C.S.,</p>
                </div>
            </div>
        </section>
    </div>
</div>